Navigation Links
The Good, Bad, Ugly of Midwest Biotech in 2003

The Good

Lets start with the good in Midwest biotech in 2003. Whats clearly striking is the outstanding performance of the publicly traded Midwest biotech companies as measured by the ePrairie Midwest Biotech Index, which evaluates the top 20 biotech stocks of the region.

Last week, I commented on the stellar performance of the Nasdaq and Amex Biotech indices, which grew ......

Full article >>> almost $19 billion raised by the biotech community in the U.S. during 2003 (an excellent year), Midwest companies accounted for a small amount of this sum (some $300 million to $400 million, both private and public) or about 2 percent of total money raised.

Considering that at least 20 percent of biotech and life science companies are located in the eight-state Midwest region, this is a......

Full article >>> ol.com. This article has been syndicated on the Wisconsin Technology Network courtesy of ePrairie, a user-driven business and technology news community distributed via the Web, the wireless Web and free daily e-mail newsletters. They can be found at www.eprairie.com.

*****
The opinions expressed herein or statements made in the ......

Full article >>>
'"/>

Source:wistechnology.com By Michael Rosen 01/06/04


Related biology technology :

1. Growth: the Good, the Bad, and the Ugly
2. Midwest life science stocks kept sizzling in Q2
3. Midwest life science stocks sizzle in a tepid first quarter
4. A Midwest passage to India, Part II
5. Midwest offers non-stop flight to North Carolina research park
6. A Midwest life-science odyssey comes full circle
7. Midwest hotter for healthcare investments
8. A Midwest small-cap, life-science surprise package
9. 2006: A mixed blessing for Midwest life science companies
10. Midwest gaining stature in nanotech research
11. Midwest colleges strong contenders for NIH funds
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... ... Parallel 6 , the leading software as a service (SaaS) provider ... Patient Encounter CONSULT module which enables both audio and video telemedicine communication between the ... the CONSULT module, patients and physicians can schedule a face to face virtual patient ...
(Date:6/27/2016)... , June 27, 2016  Liquid Biotech ... the funding of a Sponsored Research Agreement with ... tumor cells (CTCs) from cancer patients.  The funding ... CTC levels correlate with clinical outcomes in cancer ... data will then be employed to support the ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
Breaking Biology Technology:
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):